Breaking News Instant updates and real-time market news.

BLK

BlackRock

$451.45

-2.79 (-0.61%)

08:38
04/16/19
04/16
08:38
04/16/19
08:38

BlackRock says has 'deep conviction' in stability of business model

Comments from Q1 earnings conference call.

  • 16

    Apr

  • 27

    Oct

BLK BlackRock
$451.45

-2.79 (-0.61%)

01/29/19
JEFF
01/29/19
UPGRADE
JEFF
Buy
BlackRock upgraded to Buy from Hold at Jefferies
Jefferies analyst Daniel Fannon upgraded BlackRock to Buy from Hold.
01/29/19
01/29/19
UPGRADE
Target $468

Buy
BlackRock upgraded to Buy on continued industry-leading growth at Jefferies
As previously reported, Jefferies analyst Daniel Fannon upgraded BlackRock to Buy from Hold, stating that it is benefiting from both structural shifts in investor behavior as well as secular trends and he believes the company can continue to deliver industry leading organic growth and capital return. Given the reset in earnings expectations, Fannon argues that the current risk/reward "is as attractive as it has been in 4 years." He raised his price target on BlackRock shares to $468 from $427.
01/29/19
01/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nvidia (NVDA) upgraded to Buy from Neutral at UBS with analyst Timothy Arcuri saying the 20% fiscal Q4 revenue miss preannounced and the stock drop "finally sets the stage for a new positive revision cycle starting this summer." 2. American Express (AXP) upgraded to Overweight from Neutral at Atlantic Equities. 3. BlackRock (BLK) upgraded to Buy from Hold at Jefferies with analyst Daniel Fannon saying it is benefiting from both structural shifts in investor behavior as well as secular trends and he believes the company can continue to deliver industry leading organic growth and capital return. 4. British American Tobacco (BTI) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying he views the stock's valuation as attractive at current levels and feels "modestly more comfortable" with Glo's patent litigation risk in Japan. 5. 3D Systems (DDD) and Stratasys (SSYS) were upgraded to Overweight from Neutral at Piper Jaffray. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/19
LEHM
03/14/19
NO CHANGE
Target $490
LEHM
Overweight
BlackRock price target raised to $490 from $472 at Barclays
Barclays analyst Jeremy Campbell raised his price target for BlackRock to $490 from $472 citing recent increases in assets under management. The analyst keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

REGN

Regeneron

$304.81

-4.69 (-1.52%)

07:24
05/20/19
05/20
07:24
05/20/19
07:24
Recommendations
Regeneron analyst commentary  »

Barclays still bearish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 14

    Jun

  • 26

    Jun

BYND

Beyond Meat

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Initiation
Beyond Meat initiated  »

Beyond Meat initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$147.06

-1.63 (-1.10%)

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Downgrade
Clorox rating change  »

Clorox downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:22
05/20/19
05/20
07:22
05/20/19
07:22
Downgrade
Bristol-Myers rating change  »

Bristol-Myers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 31

    May

GOOS

Canada Goose

$48.34

-1.53 (-3.07%)

07:22
05/20/19
05/20
07:22
05/20/19
07:22
Initiation
Canada Goose initiated  »

Canada Goose initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPN

Superior Energy

$2.49

-0.24 (-8.79%)

07:20
05/20/19
05/20
07:20
05/20/19
07:20
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

07:20
05/20/19
05/20
07:20
05/20/19
07:20
General news
FX Update: The dollar has put a mixed performance »

FX Update: The dollar has…

MTSC

MTS Systems

$56.33

-0.13 (-0.23%)

07:18
05/20/19
05/20
07:18
05/20/19
07:18
Recommendations
MTS Systems analyst commentary  »

MTS Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$7.39

-0.62 (-7.74%)

07:17
05/20/19
05/20
07:17
05/20/19
07:17
Hot Stocks
Akoustis announces shipments, production order for 3.8GHz filters »

Akoustis announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.80

0.02 (0.05%)

07:16
05/20/19
05/20
07:16
05/20/19
07:16
Hot Stocks
AstraZeneca reports data from Novel START trial of Symbicort »

New data from Novel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

DE

Deere

$134.82

-11.15 (-7.64%)

07:15
05/20/19
05/20
07:15
05/20/19
07:15
Recommendations
Deere analyst commentary  »

Deere price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

07:13
05/20/19
05/20
07:13
05/20/19
07:13
Hot Stocks
PDC Energy CEO sends letter to shareholders, encourages white proxy card vote »

PDC Energy mailed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

HEI

Heico

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Heico analyst commentary  »

Heico price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 05

    Jun

MU

Micron

$36.06

-1.37 (-3.66%)

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CLI

Mack-Cali Realty

$22.92

-0.12 (-0.52%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Hot Stocks
Mack-Cali Realty recommends stockholders vote the WHITE proxy card »

Mack-Cali strongly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

07:10
05/20/19
05/20
07:10
05/20/19
07:10
General news
Oil prices down from highs over USD 63 »

Oil prices down from…

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TSLA

Tesla

$211.02

-17.56 (-7.68%)

07:09
05/20/19
05/20
07:09
05/20/19
07:09
Recommendations
Tesla analyst commentary  »

Tesla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

, MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

07:08
05/20/19
05/20
07:08
05/20/19
07:08
Recommendations
Alnylam, The Medicines Co. analyst commentary  »

Alnylam partner presented…

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Earnings
SpartanNash reaffirms FY19 adjusted EPS view $1.20-$1.50, consensus $1.69 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

CGEN

Compugen

$3.45

0.01 (0.29%)

, BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Hot Stocks
Compugen doses first patient in Phase 1 COM701/Opdivo study »

Compugen (CGEN) announced…

CGEN

Compugen

$3.45

0.01 (0.29%)

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 29

    May

  • 31

    May

TRK

Speedway Motorsports

$18.14

-0.035 (-0.19%)

07:06
05/20/19
05/20
07:06
05/20/19
07:06
Hot Stocks
Speedway Motorsports retains advisor to consider going private proposal »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$104.76

-2.98 (-2.77%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Recommendations
Xilinx analyst commentary at Nomura Instinet »

U.S. action against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.29

-0.07 (-1.31%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Hot Stocks
Intec Pharma granted European patent »

Intec Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
05/20/19
05/20
07:05
05/20/19
07:05
General news
Tech sector weighs on global stock markets »

Tech sector weighs on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.